Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NANOG neighbor homeobox protein (NANOGNB) is a predicted transcription factor of the homeobox family, sharing structural and sequence similarity with other Hox proteins, which are known to orchestrate gene expression patterns governing tissue and anatomical structure in early embryonic development. Like other homeobox proteins, NANOGNB most likely contains a characteristic 60-amino acid homeodomain that binds to DNA and modulates target gene expression. While classical Hox proteins are well known for specifying segmental identity and patterning, NANOGNB appears to be a lesser-characterized member; its functions are predicted based on its domain structure and sequence conservation. Homeobox proteins collectively serve as master controllers of gene regulatory networks in development, but specific data on NANOGNB's independent physiological or pathological roles are limited at this time. There are currently no drugs or therapeutics targeting NANOGNB, nor are there known clinical biomarkers or safety concerns directly associated with this protein. The gene is predicted to be involved in the regulation of transcription by RNA polymerase II, similar to other homeodomain proteins. Homeobox proteins typically play roles in segmental development and gene regulation during embryogenesis. Unlike NANOG itself (another homeobox transcription factor essential for stem cell pluripotency), NANOGNB is not firmly validated as an independent disease-associated protein or therapeutic target. It is not documented as a direct mediator of cancer, inflammation, or other pathologies to date.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NANOG neighbor homeobox protein (NANOGNB).